Dysregulation of DNA methylation patterns may identify patients with breast cancer resistant to endocrine therapy: A predictive classifier based on differentially methylated regions

Endocrine therapy (ET) is one of a number of targeted therapies for estrogen receptor-positive breast cancer (BRCA); however, resistance to ET has become the primary issue affecting treatment outcome. In the present study, a predictive classifier was created using a DNA methylation dataset to identi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Fan, Cui, Yukun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607238/
https://www.ncbi.nlm.nih.gov/pubmed/31423189
http://dx.doi.org/10.3892/ol.2019.10405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607238/
https://www.ncbi.nlm.nih.gov/pubmed/31423189
http://dx.doi.org/10.3892/ol.2019.10405

Ejemplares similares